Acquisitions, Placing and Open Offer – Circassia Pharmaceuticals

Peel Hunt is acting as joint book runner, joint underwriter and joint broker to Circassia Pharmaceuticals Plc on its £275m Placing and Open Offer of 95,469,537 new ordinary shares to fully fund the acquisitions of both Aerocrine AB (a Swedish listed company) for c. £135m in cash and, separately, the acquisition of Prosonix Limited (a UK company) for up to £100m in cash, as announced 15 May, 2015.